The latest from OTC Perspectives
Cough and Cold OTC Market to See Stable Growth in Sales
Cough and Cold OTC Market to See Stable Growth in Sales
Tuesday, 31 January 2012, 01:09 PM
From 2007 to 2012, the Cough and Cold OTC industry will increase about 1.2% annually to $2.3 billion in revenue, according to a new report from IBISWorld. This can be attributed to several factors, including “occurrence and severity of cold and flu seasons, and changes in private health insurance coverage.” The research also found that private labels will become more popular among consumers, thus they will continue to be a source of competition to the industry.
To read the news release, click here.
Related articles
Pharmacists Still Underutilized Despite Extensive Knowledge
Only approximately 1 in 3 consumers (35%) ask a pharmacist questions regarding an OTC medication, compared to half of those (51%) filling a prescription product. The
FDA Requirements Not Enough Regarding Safety of Supplements
A draft guidance by the FDA for dietary supplement manufacturers are “too weak,” wrote Dr. Pieter Cohen in a recent issue of the New England Journal of Medicine.
Supplement Advertisers Warned for Non-Compliant Advertising
The Natural Products Foundation (NPF) alerted the Federal Trade Commission (FTC) to 22 dietary supplement advertisers that were not in compliance with marketing
OTC/HBA National Advertising Award Winners Announced
Verona, NJ [May 17, 2011] - OTC Perspectives, Inc. revealed the winners of the 3rd annual OTC/HBA National Advertising Awards last week during a celebratory cocktail
OTC Perspectives Announces the Top OTC/HBA Marketers of the Year for 2011
VERONA, N.J. (April 26, 2011) — OTC Perspectives magazine, a leading publication for marketers in the consumer healthcare industry, has named its third annual list of
| ABOUT SSL CERTIFICATES |
